EPILEPSY CANADA CLINICAL TRANSLATIONAL RESEARCH AWARD 2024

Epilepsy Canada, with the support of CURE Epilepsy, is pleased to announce the 2024 Epilepsy Clinical Translational Research Award.  This investigator-initiated grant mechanism seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. Epilepsy Canada prioritizes highly innovative, paradigm-shifting projects that address both organizations’ mission to cure epilepsy, affirming our core belief that the only acceptable final goal is “no seizures, no side-effects.”

Our sole mandate is to raise monies for epilepsy research with the objective advancing treatments and finding cures.

FUND RESEARCH | FIND A CURE

Together, we identify and fund cutting-edge research, challenging scientists

worldwide to collaborate and innovate in pursuit of this goal.

Our commitment is unrelenting.

Epilepsy Canada seeks to support studies that will rapidly translate into improving the life of people with epilepsy. This grant is intended to provide funding to allow investigators at all stages to conduct a research study that is likely to influence people with epilepsy within the next two years. Researchers may propose studies related to epilepsy, epilepsy treatments and epilepsy comorbidities, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. The involvement of persons with lived experience in study development and implementation will be considered an asset. Requests may be made for up to $100,000 CDN for one year.